使用“断点棋盘平板”筛选针对产金属β-内酰胺酶的多重耐药铜绿假单胞菌的单环β-内酰胺类与氨基糖苷类联合治疗
Monobactam and aminoglycoside combination therapy against metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa screened using a 'break-point checkerboard plate'.
作者信息
Araoka Hideki, Baba Masaru, Takagi Shinsuke, Matsuno Naofumi, Ishiwata Kazuya, Nakano Nobuaki, Tsuji Masanori, Yamamoto Hisashi, Seo Sachiko, Asano-Mori Yuki, Uchida Naoyuki, Masuoka Kazuhiro, Wake Atsushi, Taniguchi Shuichi, Yoneyama Akiko
机构信息
Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
出版信息
Scand J Infect Dis. 2010 Mar;42(3):231-3. doi: 10.3109/00365540903443157.
Metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa (MDR P. aeruginosa) is a cause of life-threatening infections. With parenteral colistin not available in Japan, we treated MDR P. aeruginosa sepsis with monobactam and aminoglycoside combination therapy, with screening using a 'break-point checkerboard plate'.
产金属β-内酰胺酶的多重耐药铜绿假单胞菌（MDR P. aeruginosa）是危及生命感染的一个病因。由于日本没有胃肠外使用的黏菌素，我们采用单环β-内酰胺类抗生素与氨基糖苷类抗生素联合疗法治疗MDR P. aeruginosa败血症，并使用“断点棋盘格平板”进行筛选。
Zotero 插件